Kelly Ten Hagen | |
---|---|
Born | Kelly E. Greig |
Alma mater | Cornell University Stanford University |
Scientific career | |
Fields | Developmental glycobiology |
Institutions | National Institute of Dental and Craniofacial Research |
Doctoral advisor | Stanley Norman Cohen |
Kelly Greig Ten Hagen is an American glycobiologist and head of the developmental glycobiology section at the National Institute of Dental and Craniofacial Research. She studies O-glycosylation regulation and its relationship to human disease.
Kelly E. Greig received a B.S. from Cornell University with distinction and honors and earned a Ph.D. in genetics at Stanford University. [1] Her 1992 dissertation was titled Studies investigating the temporal order of NDA replication in mammalian cells. [2] Stanley Norman Cohen was her doctoral advisor. [2]
Ten Hagen is the associate scientific director and head of the developmental glycobiology section at the National Institute of Dental and Craniofacial Research (NIDCR). [3] Her lab studies the enzyme family and factors that regulate protein O-glycosylation and how this conserved protein modification influences organ development and function, to better understand how aberrations contribute to disease. [3]
Ten Hagen has served as an editorial board member for the Journal of Biological Chemistry and currently serves on the editorial board for Glycobiology , the board of reviewing editors for eLife and as a council member for the American Society for Biochemistry and Molecular Biology (ASBMB). She is a founding member of the Women in Biochemistry and Molecular Biology Committee within the ASBMB. Ten Hagen is an elected Fellow of the American Association for the Advancement of Science and was the co-recipient of the 2019 NIH Equity, Diversity and Inclusion Award of the year. She currently serves on the NIH Central Tenure Committee, the NIH Anti-Harassment Steering Committee and the NIH Women Scientists Advisors Committee. [1] [3]
The National Institute of Dental and Craniofacial Research (NIDCR) is a branch of the U.S. National Institutes of Health. The institute aims to improve the oral, dental, and craniofacial health through research and the distribution of important health information to the American people.
Jeremy Mark Berg was founding director of the University of Pittsburgh Institute for Personalized Medicine. He holds positions as Associate Senior Vice Chancellor for Science Strategy and Planning and Professor of Computational and Systems Biology at the University of Pittsburgh. From 2016 - 2019, Berg was editor in chief of the Science journals.
The Rare Diseases Clinical Research Network (RDCRN) is an initiative of the Office of Rare Diseases Research (ORDR). RDCRN is funded by the ORDR, the National Center for Advancing Translational Sciences and collaborating institute centers. The RDCRN is designed to advance medical research on rare diseases by providing support for clinical studies and facilitating collaboration, study enrollment and data sharing. Through the RDCRN consortia, physician scientists and their multidisciplinary teams work together with patient advocacy groups to study more than 200 rare diseases at sites across the nation.
Jeffrey David Esko, Ph.D.,M.D. (h.c) is currently a Distinguished Professor of Cellular and Molecular Medicine and Co-Director of the Glycobiology Research and Training Center at the University of California, San Diego. His research has focuses on understanding the structure, biosynthesis and biological roles of proteoglycans in mammalian cells and model organisms. Esko popularized proteoglycans through his pioneering genetic and functional studies in cells and model organisms. He discovered the dependence of tumor formation on heparan sulfate, the first small molecule inhibitors of heparan sulfate, the action of proteoglycans as receptors for hepatic lipoprotein clearance and for delivery of therapeutic agents. Esko cofounded Zacharon Pharmaceuticals. He was an editor and author of the first textbook in the Glycobiology field, Essentials of Glycobiology.
Dennis Torchia is an American biophysicist who specialized in NMR spectroscopy. He spent most of his career at the National Institute of Dental and Craniofacial Research (NIDCR), part of the United States National Institutes of Health, where he served as Chief of the Structural Biology Unit before his retirement in 2006.
Phillips Wesley Robbins is a Professor Emeritus in the Department of Molecular and Cell Biology at the Boston University School of Dental Medicine. He moved to BU in 1998 following a career of almost 40 years on the faculty at the Massachusetts Institute of Technology.
Marion Sewer (1972-2016) was a pharmacologist and professor at the University of California, San Diego's Skaggs School of Pharmacy and Pharmaceutical Sciences known for her research on steroid hormone biogenesis and her commitment to increasing diversity in science. Much of her research centered around cytochrome P450, a family of enzymes involved in the conversion of cholesterol into steroid hormones. She died unexpectedly at the age of 43 from a pulmonary embolism on January 28, 2016 while traveling through the Detroit airport.
Pamela Gehron Robey is an American cell biologist. She is a senior investigator in the skeletal biology section at the National Institute of Dental and Craniofacial Research.
Niki M. Moutsopoulos is a Greek periodontist and immunologist. She is a senior investigator in the oral immunity and infection section at the National Institute of Dental and Craniofacial Research. Moutsopoulos specializes in oral immunology and periodontitis. Her research program focuses on host-microbial interactions that can drive chronic inflammatory responses and tissue destruction in the oral cavity.
Mirit I. Aladjem is an Israeli-American biologist researching cellular signaling pathways that regulate DNA synthesis. She is a senior investigator in the National Cancer Institute's developmental therapeutics branch and head of the DNA replication group.
Natalie Porat-Shliom is an Israeli-American cell biologist and microscopist specialized in intravital microscopy to research mitochondrial structure. She is a NIH Stadtman Investigator and head of the cell biology and imaging section at the National Cancer Institute.
Marjorie Roloff Stetten was an American biochemist whose carbohydrate metabolism research led to the advancements in biomedical knowledge of enzymes and biosynthesis and the discovery of AICA ribonucleotide. During her career, she was an investigator at the National Institutes of Health and a research professor of experimental medicine at Rutgers Medical School.
Marie Ussing Nylen is a Danish-American biologist, dentist, microscopist, and badminton player known for her research on the morphology of tooth enamel and her contributions to refining the electron microscope as an aide in dental research at the National Institute of Dental and Craniofacial Research (NIDR). She was the first woman director of the NIDR's Intramural Research Program. Nylen became director of the NIDR extramural research program in 1984. In 1947 and 1953, she won the women's world singles event at the All England Open Badminton Championship.
Rachel Harris Larson was an American chemist and dental researcher who studied the interrelationships of genetics, nutrition, and bacteriology in dental caries. She was the first female scientist at the National Institute of Dental and Craniofacial Research where she worked from 1942 until her retirement in 1977.
Marian Frances Young is an American developmental biologist researching the function of extracellular matrix proteins in skeletal tissues. She is the deputy scientific director of the division of intramural research at the National Institute of Dental and Craniofacial Research.
Ophir David Klein is an American developmental biologist who specializes in pediatric medical genetics. Klein is Executive Director of Cedars-Sinai Guerin Children’s, Vice Dean for Children’s Services, Professor of Pediatrics, and the David and Meredith Kaplan Distinguished Chair in Children’s Health. He is also a professor of Orofacial Sciences and Pediatrics at UCSF.
Lawrence A. Tabak is an American dentist and biomedical scientist serving as the acting director of the National Institutes of Health. He is the principal deputy director of the National Institutes of Health. Tabak was director of the National Institute of Dental and Craniofacial Research from 2000 to 2010.
Jennifer Y. Webster-Cyriaque is an American dentist and immunologist specializing in the oral microbiome, salivary gland disease in patients with HIV, and cancer-causing viruses. She became the deputy director of the National Institute of Dental and Craniofacial Research in November 2020. Webster-Cyriaque was a faculty member at UNC Adams School of Dentistry and the UNC School of Medicine for 21 years.
Nicki Packer FRSC is a Distinguished Professor of Glycoproteomics in the School of Natural Sciences at Macquarie University and Principal Research Leader at Griffith University's Institute for Glycomics. Packer is a Fellow of the Royal Society of Chemistry and in 2021 received the Distinguished Achievement in Proteomic Sciences Award from the Human Proteome Organization. Her research focuses on biological functional of glycoproteins by linking glycomics with proteomics and bioinformatics.
Nancy Ruth Goldman Nossal was an American molecular biologist specialized in the study of DNA replication. She was chief of the laboratory of molecular and cellular biology at the National Institute of Diabetes and Digestive and Kidney Diseases from 1992 to 2006.